About this event
For a long time, we have known that we live in a microbe’s world. However, we are only just piecing together the importance of how interactions with our innate microbiomes influence our health.
Join us for this unique 3-part series, where we explore how metagenomics and microbiome sequencing is uncovering the hidden traits of the invisible world.
11th February - 3pm GMT / 4pm CET/ 10am EST
Studying the interactions between microbes and hosts have been enabled by a multitude of technologies to study the complex interactions between microbiome-host multi-omics.
This webinar will focus on the technologies that are driving microbiome research and how they can be successfully integrated for studies.
The intersection between the microbiome and its host via metabolomics – Elliot Friedman, Director for Data Integration, Penn Center for Nutritional Science & Medicine, University of Pennsylvania
Multi-omic exploration of complex phenotypes in pediatric autism spectrum disorder – Ruth Ann Luna, Director of Medical Metagenomics, Baylor College of Medicine
Investigating extra-intestinal manifestation of Crohn's disease via host and microbiome sequencing – Connie Ha, Postdoctoral Scientist, Cedars-Sinai
Harnessing the Power of Metabolomics to Elucidate Microbiome Function - Brian Keppler, Director, Discovery and Translational Sciences, Metabolon
18th February - 3pm GMT / 4pm CET/ 10am EST
The microbiome is known to play a role in various human diseases. This webinar will focus on research to improve our understanding of the role the microbiome plays, and what this might mean for future therapeutic intervention.
Assessing health using gut microbiome profiling - Jaeyun Sung, Assistant Professor, Microbiome Program, Center for Individualized Medicine, Mayo Clinic
Bugging the gut: engineering bacteria to eavesdrop - David Riglar, Principal Investigator, Imperial College London
25th February - 3pm GMT / 4pm CET/ 10am EST
Interactions between the host-microbiome are thought to influence a range of disease areas: from cancer to neurobiological disorders. This webinar will highlight a few recent studies that search for host-microbiome interactions that may be targetable.
High-Throughput inference of drug exposure effect on intestinal microbiota in vivo - Antonio Gomes, Computational Biologist, Memorial Sloan Kettering Cancer Center
Using genomics to predict metabolic exchange between microbiota and human cells in colon cancer - Beth Adamowicz, Postdoctoral Associate, Blekhman lab, University of Minnesota
Front Line Genomics is a genomics-focused media company, with a social mission to deliver the benefits of genomics to patients faster. We organise the Festival of Genomics, digital events, reports, webinars and digital events, as well as operating a content-rich website.
Share this event